Migraine: Safety & Efficacy of Anti-CGRPs and Patient Selection

preview_player
Показать описание
Thought leaders discuss the safety and efficacy of anti-CGRP monoclonal antibodies for migraine and for which patients treatment may be successful.
  1. NeurologyLive
Рекомендации по теме
Migraine: Safety & 0:07:04

Migraine: Safety & Efficacy of Anti-CGRPs and Patient Selection

Migraine Prevention: New 0:56:52

Migraine Prevention: New Opportunities for Pain Relief

Efficacy and safety 0:01:24

Efficacy and safety of CGRP-directed antibodies in migraine

Researchers Unveil Efficacy 0:02:03

Researchers Unveil Efficacy and Safety of New Migraine Drug

Treatment and prevention 0:00:42

Treatment and prevention of migraine

A New Era 0:24:15

A New Era of Migraine Management

Trudhesa: A New 0:11:33

Trudhesa: A New Delivery System for DHE - Spotlight on Migraine S3:Ep31

PROMISE-1 & PROMISE-2: 0:01:08

PROMISE-1 & PROMISE-2: eptinezumab in episodic and chronic migraine

NVJC Ep. 43 0:26:26

NVJC Ep. 43 Headache/Migraine: Efficacy of Ubrogepant in the Acute Treatment of Migraine

Peter Goadsby, EAN 0:03:30

Peter Goadsby, EAN 2018 – Erenumab in difficult-to-treat episodic migraine: LIBERTY study

The Relivion Device 0:12:05

The Relivion Device for Migraine Treatment - Spotlight on Migraine S3:Ep33

Acute Treatment of 0:46:18

Acute Treatment of Migraine with Gepants: When You Need to Act Fast

Unprecedented Efficacy of 0:07:36

Unprecedented Efficacy of CGRP Inhibitors for Migraine

Onset of migraine 0:02:02

Onset of migraine preventive effects with rimegepant in a Phase II/III trial

The efficacy of 0:01:41

The efficacy of symptomatic treatments in children and adolescents with chronic migraine

The Role of 0:08:01

The Role of CGRP as Targeted Treatment for Migraine - Module 4: TEV-48125

New Treatment Targets 0:00:56

New Treatment Targets PACAP for Migraine Prevention

The State of 0:06:12

The State of Monoclonal Antibodies for Migraine

Safety Considerations in 0:03:18

Safety Considerations in the Treatment of Migraine

AMIQT - Dr 0:12:24

AMIQT - Dr , Evgeny Purrgin: Fremaneumab for the Prevention of Migraine

Christopher Gottschalk, MD: 0:01:56

Christopher Gottschalk, MD: Long-Term Safety in Preventive Migraine Therapies

CGRP Inhibitors as 0:04:25

CGRP Inhibitors as Preventative Migraine Therapy

The Role of 0:05:05

The Role of CGRP as Targeted Treatment for Migraine - Module 5: ALD403

Pipeline Acute Treatment 0:11:10

Pipeline Acute Treatment for Migraine: AXS-07 - Spotlight on Migraine S3:Ep8